Mark L. Berch

Array ( [id] => 7412588 [patent_doc_number] => 20040176590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Manufacture of cefalosporins and intermediates' [patent_app_type] => new [patent_app_number] => 10/374723 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6577 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176590.pdf [firstpage_image] =>[orig_patent_app_number] => 10374723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730809 [patent_doc_number] => 20030186999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Purine derivatives having, in particular, antiproliferative properties, and their biological uses' [patent_app_type] => new [patent_app_number] => 10/372670 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7390 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186999.pdf [firstpage_image] =>[orig_patent_app_number] => 10372670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386347 [patent_doc_number] => 20040082570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Xanthine derivative and DPPIV inhibitor' [patent_app_type] => new [patent_app_number] => 10/374918 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62155 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082570.pdf [firstpage_image] =>[orig_patent_app_number] => 10374918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6857011 [patent_doc_number] => 20030130512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Process for the production of purine derivatives and intermediates therefor' [patent_app_type] => new [patent_app_number] => 10/369841 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3950 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130512.pdf [firstpage_image] =>[orig_patent_app_number] => 10369841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730807 [patent_doc_number] => 20030186997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => '2,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonsulsive action and methods for producing the same' [patent_app_type] => new [patent_app_number] => 10/333504 [patent_app_country] => US [patent_app_date] => 2003-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3292 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186997.pdf [firstpage_image] =>[orig_patent_app_number] => 10333504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1131620 [patent_doc_number] => 06787649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-07 [patent_title] => 'Cephalosporin intermediates' [patent_app_type] => B2 [patent_app_number] => 10/258624 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2962 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787649.pdf [firstpage_image] =>[orig_patent_app_number] => 10258624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 981910 [patent_doc_number] => 06926763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-09 [patent_title] => 'Purine and isosteric antibacterial compounds' [patent_app_type] => utility [patent_app_number] => 10/364024 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15256 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/926/06926763.pdf [firstpage_image] =>[orig_patent_app_number] => 10364024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664576 [patent_doc_number] => 20030203902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Nonsteroidal gestagens' [patent_app_type] => new [patent_app_number] => 10/358173 [patent_app_country] => US [patent_app_date] => 2003-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16582 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203902.pdf [firstpage_image] =>[orig_patent_app_number] => 10358173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865560 [patent_doc_number] => 20030191086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof' [patent_app_type] => new [patent_app_number] => 10/358674 [patent_app_country] => US [patent_app_date] => 2003-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17091 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191086.pdf [firstpage_image] =>[orig_patent_app_number] => 10358674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725567 [patent_doc_number] => 20030207879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => '8-Heteroaryl xanthine adenosine A2B receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/357865 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27142 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207879.pdf [firstpage_image] =>[orig_patent_app_number] => 10357865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206550 [patent_doc_number] => 20050043289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Crystalline hydrochloride of 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxyimino)acetyl)amino)-3-((imino-1-piperazinylmethyl)methylhydrazono)-methyl-3-cephem-4-carboxylic acid' [patent_app_type] => utility [patent_app_number] => 10/499616 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4701 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043289.pdf [firstpage_image] =>[orig_patent_app_number] => 10499616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7402193 [patent_doc_number] => 20040019095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'N, N\'-dimethylated N-confused porphyrins' [patent_app_type] => new [patent_app_number] => 10/353787 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10338 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019095.pdf [firstpage_image] =>[orig_patent_app_number] => 10353787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809589 [patent_doc_number] => 20030199528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Hetrocyclic compounds that are inhibitors of the enzyme DPP-IV' [patent_app_type] => new [patent_app_number] => 10/353181 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17267 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199528.pdf [firstpage_image] =>[orig_patent_app_number] => 10353181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797825 [patent_doc_number] => 20030176699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Purine inhibitors of protein kinases, G proteins and polymerases' [patent_app_type] => new [patent_app_number] => 10/352752 [patent_app_country] => US [patent_app_date] => 2003-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9480 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176699.pdf [firstpage_image] =>[orig_patent_app_number] => 10352752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740805 [patent_doc_number] => 20030158174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Crystalline 1-methylcarbapenem derivatives' [patent_app_type] => new [patent_app_number] => 10/351944 [patent_app_country] => US [patent_app_date] => 2003-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7823 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158174.pdf [firstpage_image] =>[orig_patent_app_number] => 10351944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 453196 [patent_doc_number] => 07247630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'Uses of tricyclic compounds' [patent_app_type] => utility [patent_app_number] => 10/349935 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22851 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247630.pdf [firstpage_image] =>[orig_patent_app_number] => 10349935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7679004 [patent_doc_number] => 20030195332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'PNA monomer and precursor' [patent_app_type] => new [patent_app_number] => 10/351173 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18344 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20030195332.pdf [firstpage_image] =>[orig_patent_app_number] => 10351173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7164009 [patent_doc_number] => 20050085638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Process for producing dioxolane nucleoside analogues' [patent_app_type] => utility [patent_app_number] => 10/502440 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6842 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085638.pdf [firstpage_image] =>[orig_patent_app_number] => 10502440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7438385 [patent_doc_number] => 20040002601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Method for producing cephalosporins' [patent_app_type] => new [patent_app_number] => 10/347459 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2244 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002601.pdf [firstpage_image] =>[orig_patent_app_number] => 10347459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6707013 [patent_doc_number] => 20030153747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Purification process' [patent_app_type] => new [patent_app_number] => 10/348569 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5045 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153747.pdf [firstpage_image] =>[orig_patent_app_number] => 10348569 [rel_patent_id] =>[rel_patent_doc_number] =>)